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Abstract
Intraoperative MRI (ioMRI) has evolved since it used in 1991. ioMRI has been 
effective tool not only in glioma surgeries but also in other neurosurgical proce-
dures. It provides real time information with high quality resolution and it is not 
affected by brain shift. ioMRI images can be uploaded in the navigation which helps 
in further resection of residual tumors. ioMRI can be used for confirmation of com-
plete excision of tumor or location of microelectrode catheter tip DBS/sterotatic 
biopsy. It provides valuable information like location and amount of residue which 
guides surgeon for further resection safely as possible. ioMRI requires specialized 
operation theater with MRI compatible instruments which makes this setup expen-
sive and it is available in only few centers across the globe.
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1. Introduction
In 1991 at the Brigham and Women’s hospital first intraoperative MRI (ioMRI) 
was used. Since then, its use and techniques have evolved. It is the most accurate 
imaging in intraoperative setting as it provides the real time information of tumor 
residue and guides further resections even if anatomy is distorted by brain shift 
[1]. The extent of resection is a prognostic factor in most tumor surgeries, like 
surgery for gliomas. These patients will benefit from ioMRI. The role of ioMRI is 
not only restricted to gliomas but other tumors/procedures as well. Designated 
operation theaters, operative instruments and MRI-compatible monitoring devices 
were required for ioMRI which has made this an expensive modality, with only few 
centers in the world able to afford such a facility. In this chapter we will discuss 
about types of ioMRI, anesthesia considerations and its role in different types of 
neurosurgical procedures.
2. Evolution and types of ioMRI
The first intraoperative MRI for neurosurgical operations, was developed in 
1991 by the combined efforts of the Departments of Neurosurgery and Radiology 
of the Brigham & Woman’s Hospital of the Harvard Medical School in Boston 
and the General Electric Medical Systems [2]. It was 0.5 T open type. Low field 
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open type with Horizantal gap MRI was used for interventional procedures 
by Gronemeyer and colleagues [2, 3] which provided access to patients. Later 
Vertical gap MRI was developed which increased patient access and was used for 
various interventional, endoscopic and open surgeries. Many MRI compatible 
equipment had been developed since then along with ioMRI, with all ferromag-
netic instruments replaced with titanium. The main drawback for open type 
configuration has been low field strength of magnet which does not yield good 
image resolution. Both vertical and horizontal systems had double doughnut 
magnets. The IMRIS system was developed later by a neurosurgeon, Dr. Garnette 
Sutherland of Calgary, Alberta, Canada. This system offered a uniquerail-
mounted MRI system in which the scanner could be mobilized to the patient. It 
was closed type 1.5 T ceiling mounted rail system, which was moved between 
two rooms [4].
ioMRI scanner can be open or closed type. Open type (with horizontal gap or 
vertical gap) has better access to patient while compromising on image quality. 
Closed type (small bore or long bore) has better quality of images with no access to 
the patient.
Based on field strength ioMRI are classified as low field (0.2 T), mid field 
(0.5 T) and high field (1.5 T & 3 T). Low-field systems are the GE Signa, the 
Hitachi 0.3 tesla system, and the Polestar0.15 tesla system. SIGNA SP 0.5 T is 
a midfield ioMRI system. High-field systems are Siemens Brain Suite, IMRIS 
system, and the Philips systems. High field ioMRI provides good quality of 
images with better spatial and contrast resolution with precision and some of the 
studies like perfusion, DTI and fMRI are possible compared to low or mid field 
ioMRI [5, 6].
The imaging in ioMRI can be truly intraoperative or interoperative in nature. 
Intraoperative imaging is done while surgery is ongoing in the scanner without 
any interruption of procedure. Horizontal and vertical donut models were used for 
it. These are mid field ioMRIs. These are the actual real time imaging which were 
performed during the surgery similar to fluoroscopy. The draw backs of this system 
were poor image quality, need of MRI compatible instruments including micro-
scope, navigation which were very expensive and space constrains for movement. In 
interoperative imaging, surgery is stopped temporarily and either patient or gantry 
mobilized to acquire images. This type has been developed more commercially as 
there is no need for continuous intraoperative imaging and imaging is required only 
for certain periods like, to confirm extent of resection, location of residue or guid-
ing further resection. This type allows installation of high field strength MRI in the 
area near the operating room or within the same room with operating table outside 
of the 5 gauss line. This allows surgeon to use non-MRI compatible instruments dur-
ing surgery. Patient transportation is the main drawback which takes 20–40 minutes 
and requires proper trained staff [4].
High field ioMRI operative rooms (OR) are of different types. First type was 
IMRIS. In this type MRI was rail mounted and placed between two operating rooms 
and mobilized into the OR when required. During imaging instruments moved 
beyond the 5 gauss line. The operating rooms had to be RF shielded to acquire 
good images. Second type was RF shielded OR in which MRI and operating table 
are in the same room, when imaging is required, patient is moved into gantry to 
require images. This type has a rotating table, during surgery head end of the table 
is beyond 5 gauss line. When imaging is planned table is rotated so that head goes 
into the gantry. This was developed by Siemens and BrainLab companies combined. 
BRAIN SUITE is an integrated operative area away from the magnet in which inter-
ventional procedures can be done. MRI compatible instruments are not required.  
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It also has incorporated Neuronavigation with auto registration. All of these systems 
are possible in high volume centers or in institutes with research interest, as the cost 
is prohibitive [4]. Other more commercially viable concept is “nearby OT type” –in 
which MRI machine is fixed in separate room adjacent to OR and operating table 
is transferred into MRI suite. In nearby OT type, the MRI can be used for imaging 
other patients through separate entry to access the MRI which can be cost effective. 
Whenever ioMRI is planned the MRI is room is cleaned and sterilized, the outside 
entry is closed and OR entry is opened to receive the patient in operative position 
draped, under anesthesia. All these require special protocols, trained staff, and 
proper communication between MRI technician, surgeon, anesthesiologist and 
OT staff.
Authors are using “Nearby OT model” – Siemens 3 T ioMRI and have found to 
be cost effective. Initially it took around 85.6 minutes for shifting in and out ioMRI 
and restart surgery which latter reduced to 37.4 minutes by multiple mock drills and 
continuous training of involved staffs [7, 8] (Figure 1).
3. Anesthesia considerations
The main challenge during ioMRI anesthesia is to have uninterrupted access 
to the patient while allowing high-quality real-time MRI images with minimal 
electrical noise interference. All standard monitors, equipment and anesthesia 
workstation should have minimal electrical noise interference and MRI compatible. 
Monitors can be classified as MRI unsafe (prohibited inside suite), MRI conditional 
(permitted not beyond 5 Gauss line inside the MRI suite), MRI safe (can be allowed 
freely inside the suite) [9].
Anesthetist should be aware of ECG changes like ST segment changes, P wave 
abnormalities, AF, Ventricular fibrillation can happen due to static magnetic field, 
pulse gradient and high frequency field. If these changes occur along with hemody-
namic instability then it should be managed accordingly.
All patients should be screened for any metallic objects, piercings, tattoos (lead), 
metallic implants, pacemakers, deep brain stimulators, implantable defibrillator, 
vagal stimulator, aneurysmal clips during pre-operative assessment to know the 
MRI compatibility.
During ioMRI patient access is limited and so all IV lines and tubings should 
be long, tightly fixed and secured. Proper checklist has to be followed to avoid 
mishaps and accidents. Anesthesia depth has to be maintained throughout the 
Figure 1. 
Representational images. A. RF shielded ioMRI OT in which MRI moved towards operating table B. Nearby 
OT model, in this model patient shifted on mobile MRI compatible table top.
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procedure either with intravenous or inhalational anesthesia. Nitin et al. [10] 
reported thermal injuries due to radio frequency energy. It can be avoided with 
skin to skin packing, avoiding looping of wires, lines and tubing. Noncompatible 
equipment (Temperature probe and depth monitors and flexometallic tubes) 
are removed. Nitin Manohar et al. [11] also reported that IONM electrodes can 
interfere with the signals and produce artifacts affecting the image quality. Patient 
positioning for ioMRI requires additional attention. Position should be tailored 
so that head fixed to the head clamp moves freely within the ioMRI bore. ioMRI 
compatible Mayfield clamps are used for positioning and final position should be 
confirmed with bore gauge that is provided along with ioMRI compatible opera-
tive table, to avoid possible collision with the gantry. During awake procedure or 
surgery, preoperative counseling regarding the MRI sound, use of ear plugs and 
sedation should be done.
Emergency drugs should be ready in case of contrast induced reactions or 
hemodynamic instability during the scan. Mock drills to cope up with emergency 
situations for all OT and MR staff should be done with everyone knowing all 
steps and well versed in their roles with even quenching of MRIif needed 
(Figures 2 and 3) (Box 1).
Figure 2. 
MRI compatible instruments A. Laryngoscopes, B. Monitor, C. Ventilator, D. Infusion pump and E. ECG 
electrodes.
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Figure 3. 
Positioning of patient in operative table with MRI compatible Mayfield clamps and navigation probe. Final 
position is confirmed using bore gauge so that patient moves in and out of MRI machine freely.
CHECKLIST FOR INTRA-OP MRI:
(To be Completed mandatorily prior to Wheeling-1a; Please Tick on the boxes on checklist 
completion)
• MRI Compatible ECG electrodes:     □
• No metallic ornaments:      □
• No metallic Implants, Heart valves, Pacemakers in patient:   □
• Arms insulated from body:      □
• Padding from skin to skin:      □
• No staplers, sand bags, metal objects in sheets, sisters check done:  □
• OT table sheets tucked under to help sliding:    □
• Temp probe removed:      □
• Bag free:       □
• Warmer disconnected:      □
• Antibiotic repeated:      □
• Inform MRI Technician:      □
• Cautery pad removed:      □
• Emergency drugs box sent in:     □
• OT personnel moving into the MRI Suite screened for metallic objects:  □
• MRI Compatible Monitor Ready:     □
• MRI Anaesthesia Machine SWITCHED “ON” CHECKED:   □
• OT Table & MRI Table ALIGNED & LEVELLED    □
• Infusion pump casing:      □
• Long breathing circuit (Double):     □
• Long IV line extension (200 ml):     □
• Long infusion extension (200 ml):     □
• AMBU, Bains circuit ready      □
• Compatible Laryngoscope Ready:     □





4. Role of ioMRI in neurosurgery
It is useful in both intra and extra axial tumors. Depending upon the situation 
ioMRI can be used as completion study, residue seeking or guidance for further 
resection. It is also used in epilepsy surgery, deep brain stimulation (DBS), sterotac-
tic biopsies. Apart from extent of resection and location of residue, ioMRI also gives 
us information like hematoma in and around operative cavity, ischemia (diffusion 
restriction), hydrocephalus, location of electrode tips in DBS, proximity to neuro-
vascular bundles which guides surgeon for further planning and proceeding in the 
same sitting of surgery.
4.1 Intraaxial tumors
Gliomas are the most common primary brain tumors. These are infiltrating 
tumors along the subcortical white fibers. In low grade gliomas it is difficult to 
differentiate from adjacent normal tissue. During surgery extended resection can 
cause neurological deficits or inadequate resection may leave significant residue 
which can progress, decreasing overall survival of the patient. Preoperatively MRI 
is usually done in patients with glioma which gives us valuable information about 
the nature of the lesion. Important sequences being FLAIR, contrast study, perfu-
sion study, DTI, functional MRI (fMRI)and spectroscopy. Information from these 
sequences are compared with the ioMRI providing the valuable information for 
improving the safety and efficacy of the resection [12–14].
ioMRI is an ideal tool for the resection of low grade gliomas (LGGs) because of 
their superior resolution in differentiating tumor from the surrounding brain, it 
allows accurate localization of residual tumor. It allows near-real-time assessment 
of extent of resection and also allows correcting for the brain shift, a disadvantage 
for Neuronavigation, which happens as surgery progresses. In LGGs, ioMRI flair 
sequence compared with preoperative image shows the residual tumor. Perfusion 
study will demonstrate the hyperperfusing area around the surgical cavity and 
thereby increase the extent of resection. In high grade gliomas (HGGs) usually the 
lesions are contrast enhancing, post-contrast study in ioMRI will show us the extent 
of resection of contrast enhancing tumor. Perfusion study helps us to identify the 
hyperperfusing areas in the non-enhancing part of HGGs which can be resected. 
Resecting hyperperfusing areas in HGGs will definitively increase the extent of 
resection and thereby increasing progression free survival [12–14] (Figures 4 and 5).
Figure 4. 
A. Preoperative MRI of a patient showing T2 hyperintense LGG involving right medial frontal lobe B. ioMRI 
showing residue around the surgical cavity which was excised in the same sitting. C. Post-op MRI showing.
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ioMRI is a valuable tool in awake craniotomy. ioMRI shows the location of resid-
ual tumor and one can perform fMRI to correlate its position with eloquent areas. 
If the residue is in the region of BOLD signals of fMRI then one can leave behind 
the residue without causing any permanent neurological deficits. Intraoperative 
neuromonitoring will guide us the intactness of long fiber tracts. ioMRI in intra-
axial tumors involving or in proximity with these tracts will tell us the extent of 
residue as well as the intactness of tract using DTI imaging. During resection of the 
intraaxial tumors, sometimes the wall of cavity collapses and blinds a part of tumor. 
Deep seated tumor or tumorat difficult angles/corners may be left behind. These 
tumor residues can be located and resected with ioMRI guidance with additional 
navigation support from the newly acquired images [12–14].
In the prospective studies done by Senft and colleagues [15] and Hatiboglu and 
colleagues [16] with ioMRI guidance, it was established that the MRI group had 
a complete resection of their enhancing tumor compared with the control group 
[4, 16]. Also in nonenhancing tumors Hatiboglu and colleagues showed increased 
complete resection from 63–80% with the help of ioMRI [16]. Pamir MN et al. 
studied 56 patients of LGG who underwent resection with ioMRI. They found that 
the use of ioMRI increased the number gross total resection of from 31 to 41, up 
by 32.3% [17]. Coburger and colleagues in their multicenter retrospective assess-
ment of LGGs surgery under ioMRI guidance showed that high-field ioMRI was 
significantly associated with gross total resection (GTR). WithGTR in 85% of cases 
compared with 57% with a low-field ioMRI [18]. Similarly ioMRI also used in other 
intraaxialtumorsandintraventicular tumors, which guides the extent of resection 
and location of residue.
With ioMRI we had achieved significant reduction in residual tumor volume. 
The mean residual tumor volume improved from 22.5 cm3 to 11.7 cm3 after ioMRI 




ioMRI role is well established in the pituitary tumors. It is important for both 
functional and nonfunctional pituitary adenomas. With the advent of endoscopic 
Figure 5. 
A. Preoperative MRI of patient with high grade lesion which was contrast enhancing, involving left caudate 
and periventricular region. B. ioMRI shows no residue of the contrast enhancing lesion.
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pituitary excision the extent of resection has significantly increased compared 
to that of the microscopic approach, though the complete excision is still around 
50–60%. The residual disease is strongly associated with complications like 
postoperative hemorrhage, need for adjuvant radiotherapy or hormonal therapy, 
significant higher risk of adenoma regrowth and possibly reduced life expectancy. 
Thus Gross total resection is recommended for both NFPAs and FPAs. With ioMRI 
one can locate the residue and chase it. In functional adenomas complete resec-
tion is mandatory to achieve cure, with ioMRI it is achievable. With ioMRI normal 
pituitary can be identified and preserved so that we can avoid post-operative 
hypopituitarism [19–21].
In various large series involving non-iMRI-guided transsphenoidal endoscopic 
resection of pituitary tumors, Dehdashti AR et al. [22] reported gross total resec-
tion of 79% and Serra C et al. [23] reported between 44–88%, while on analysis of 
studies that involved iMRI guided eTSS for PAs, average initial gross total resec-
tion rates at iMRI was only 51% which was increased to 73% help of ioMRI guided 
resection [24]. Berkmann et al. [25] observed new onset hypopituitarism of any one 
of the axes in 29% patients in iMRI guided resection group versus 45% in control 
group operated without iMRI guidance. They also observed that post-operatively 
RT was required in 3 patients in group without ioMRI compared to that none of the 
patients in ioMRI group.
ioMRI also used in craniopharyngiomas, one can assess whether adequate 
decompression has been achieved like decompression of optic chiasm. It also 
gives us information about contrast enhancing residue if any that is accessable for 
resection.
In our centre with ioMRI, we achieved gross total resection rate from 52–80%  
(p value <0.05) in 57 patients of pituitary macroadenoma (Figure 6).
4.2.2 Other extra axial lesions
Large extra axial lesions in the CP angle and skull base are difficult to excise 
completely due to its relations with cranial nerves, blood vessels and vital neural 
structures like brainstem. Due to its complexitysometimes surgeons lose the direc-
tion or leave behind large residues. In such cases ioMRI gives valuable information 
about volume and location of the residual lesion. When gross total resection of skull 
base lesions is not feasible then ioMRI can be a used for tailored tumor resection. 
Figure 6. 
A. Pre-operative MRI showing pituitary macroadenoma B. ioMRI showing residue (arrow) in left side which 
was removed in the same sitting after ioMRI.
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With ioMRI one can achieve maximum safe resection and decrease the size of 
residue so that it can become suitable for sterotactic radiosurgery [26] (Figure 7).
Mario Giordano et al. [27] recruited 19 patients of para-sellar meningiomas 
includes clinoidal, tuberculum sellae, and cavernous sinus who underwent surgical 
resection using intraoperative MRI. In 7(37%) of 19 patients, further tumor resec-
tion was performed based on information from the ioMRI. 56% of patients with 
cavernous sinus meningioma benefited by ioMRI by further safe resection of tumor. 
Dr. Chakraborty et al. [28] conducted a retrospective review of 70 operations per-
formed on 66 patients with intracranial meningiomas. Among them 30 were skull 
base meningiomas. 9(12.8%) patients required additional tumor resection based on 
ioMRI findings, and in 4 patients (6%), ioMRI imaging allowed for the avoidance of 
further dissection near-critical neurovascular structures (Figure 8).
Hussam Metwali et al. [29] performed a retrospective analysis of 15 patients 
with skull base chordomas with ioMRI. 8 patients had complete resection con-
firmed by ioMRI. Out of 7 patients 3 hadtumor residual requiring further resection 
was located in the clivus and in 4 patients in the intradural space. All the intradural 
residue patients had significant improvement in preoperative deficits which was 
possible with ioMRI guidance for locating the residue. Joseph C. Dort et al. [30] did 
a prospective, non-randomized, cohort study on 31 patients with skull base lesions. 
Figure 7. 
A&B preoperative CT image showing CP angle meningioma, C. ioMRI showing the residue along the brainstem 
which was difficult to mobilize hence it was left behind and size was less than 2 cm which was subjected for 
SRT, D post*-operative CT showing residue without any operative site hematoma. In this patient ioMRI helped 




All these patients underwent surgery in a 1.5-Tesla ioMRI suite. 11 out of 31 patients 
surgical course altered with the help of ioMRI and maximum safe resection was 
achieved. ioMRI is a valuable adjunct to skull base surgery.
In our center we did ioMRI in 30 skull base meningiomas. 16 patients had 
residual lesion, of which 12 patients had subjected for further resection in same 
sitting. They had significant reduction in volume of residual lesion. we achieved 
Simpson grade 2 excision in 6 out of 12 patients. Other 4 patients, residual lesion 
was not chased due to its proximity to neurovascular structures.
5. Other neurosurgical procedures
Epilepsy surgery has evolved over the past few decades. ioMRIisalso a valuable 
tool to achieve complete resection of abnormal areas especially those with lesions. 
Nilesh S. Kurwale et al. [31] studied on role of ioMRI in achieving seizure control 
in 39 pharmacoresistant epilepsy patients. This study included tumor (31%), 
focal cortical dysplasia (28%), mesial temporal lobe surgeries (18%), and discon-
nectionsurgeries (23%). In lesionalgroupioMRI helped infurtherresections about 
21% (5/23) patients. Complete resection was achieved in 87% of patients. ioMRI 
increases the extent of resection especially in lesionalepilepsy surgeries and thereby 
good seizure outcomes. Kaibara et al. [32] reported about50% patients had residual 
hippocampus in ioMRI aiding further resection resulting in 93% seizure freedom 
Figure 8. 
A&B ioMRI images of sphenopetroclival meningioma, initially tumor was decompressed by subtemporal 
approach but due to intra operative bleeding and hard calcified which was unable to mobilize. In this case 
ioMRI helped surgeon to approach by retromastoid craniotomy and achieve further resection of tumor as safely 
as possible in the same sitting. C&D. post-operative MRI images showing residual tumor. Volume of the residue 
is significantly reduced compared to that of in ioMRI.
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at 17 months. Michael Buchfelderet al. [33] assessed 61 patients with pharmacore-
sistant epilepsy. In this study 32 nonlesional cases underwent surgery using ioMRI, 
the extent of the tailored 28 temporal resection and 4 callosotomy was well docu-
mented. Out of 29 lesional cases the complete resection was done in 23 patients. In 
three patients lesion was extending into eloquent areas and further resection was 
not done. In other 3 patients ioMRI enabled to achieve complete resection. ioMRI 
evaluates the extent of resection or disconnection in epilepsy surgery.
ioMRI during DBS surgery provides real time confirmation of lead placement 
and other complications. Commonly the microelectrode placement in DBS is done 
with intraoperative microelectrode recording (MER) in awake conditions. With 
evolution of ioMRI now a days DBS is being done with ioMRI alone or along with 
MER. Zhiqiang Cui et al. [34] have done microelectrode placement for movement 
disorder patients under local anesthesia with MER and ioMRI. 56 (27%) of 206 
DBS electrodes were adjusted after initial ioMRI. Another 6 times repositioned after 
2 and 3 ioMRI in the same sitting. ioMRI revealed intraparenchymal hemorrhages 
in 2 patients. Martin Jakobs et al. [35] performed 86 surgeries in 81 patients with 
Parkinson’s disease, essential tremor and dystonia with intraoperative stereotactic 
MRI-only DBS electrode implantation. A total of 167 electrodes were implanted. In 
96.5% of cases the surgeries could be finished as planned. Both length of surgery 
and the time spent in the stereotactic frame could be significantly reduced. Caio 
M. Matias et al. [34, 36] evaluated placement accuracy and clinical outcomes in 
patients with frame-based stereotaxy and ioMRI without MER after induction 
under general anesthesia in DBS patients. 33 patients underwent implantation, 
64 leads in total. MR images were acquired immediately after the procedure and 
fused to the preoperative plan to verify accuracy. At the last follow-up there was 
significant improvement (p < 0.001) in symptoms compared to preoperative state. 
Placement of microelectrodes in DBS with ioMRI reduces the operative time as well 
as the time in frame. Microelectrode tip location can be confirmed and also any 
intraoperative complications can be diagnosed. ioMRI is not affected by brain shift 
due to csf leak or intracranial air, but one has to be aware of the artifacts created 
by these electrodes. Role ioMRI in DBS is certainly promising and needs further 
validation in future.
6. Future directions in ioMRI
AMIGO (Advanced Multimodality Image Guided Operating Suite) is a three-
room configuration involving the PET-CT room, operating room, and MRI room. 
It involves multidisciplinary teams to guide treatment before, during, and after 
surgery in the operating room. PET provides functional and metabolic informa-
tion with molecular biomarkers. The combination of MRI and CT with PET gives 
anatomical, functional, and metabolic combined information to surgeons intraop-
eratively for further decision-making [37].
MRI-guided focused ultrasound (MRgFUS) is a noninvasive thermal ablation 
method.IT uses MRI for target identification, planning, and energy deposition. 
It allows to ablate targeted tissue without damaging normal structures. MRgFUS 
has been approved for the treatment of uterine fibroids. It is also evaluated for 
targeted drug delivery and gene therapy, which can temporarily change vascular 
or cell membrane permeability and release or activate various compounds. High 
field strength of MRI (3 T) aids better quality of images it helps both diagnosis and 
surgical ablation. 3 T MRI also has improved sensitivity to temperature measure-
ments which enables multi-slice or three-dimensional thermometry. Trails are 
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The Smart Cyber Operating Theater (SCOT), the next generation operating 
room has been developed by Japan Agency for Medical Research and Development 
with AMED. It has a treatment room communication interface called “OPeLiNK” 
which projects all the information like patient data, navigation, IONM, anesthesia 
monitoring, operative field, ioMRI, etc. in a 70 inch screen. Approximately 20 types 
of equipment are connected to the system. Surgical information from these sources 
are sent through an application and displayed to the surgeon and it enables preci-
sion in surgery with low risk and high therapeutic effect [39].
7. Conclusion
ioMRI is a valuable tool which not only locates the residue but also guides 
further resections with enhanced safety. Its importance has been well documented 
in pituitary surgeries and gliomas. The drawbacks of ioMRI are the cost and time 
involved. But it is certainly beneficial for the patients in terms of improved func-
tional outcomes and survivals.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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